MedCity News: APP and the Wallace H. Coulter Foundation created a $20 million endowment aimed at translating biomedical research into commercial products and clinical practices. “With the Coulter process, there is strong emphasis on the successful transfer to commercialization,” said Jeffrey Duerk, chairman of biomedical engineering.